1887

Abstract

Dynamics of anti-M antibody response following intranasal infection with group A (GAS) M-18 were investigated in a Swiss albino mouse model. Mice arranged in three groups were inoculated intranasally with 2.0 × 10 c.f.u. ml of GAS M-18 on 1, 2 alternate and 3 alternate days. Plasma collected from the retro-orbital plexus was tested for antibodies by an in-house indirect ELISA. The antibody titres of the plasma samples varied from 1 : 8 to 1 : 1024 in the 1 day dose, from 1 : 4 to 1 : 256 in the 2 day dose and from 1 : 4 to 1 : 128 in the 3 day dose. Peak titres were seen on day 42 or 56 and in all cases the titres had declined by day 84. Swiss albino mouse can thus serve as a useful animal model to study different aspects of type-specific anti-M immune responses against GAS disease when designing candidate streptococcal vaccines.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.45555-0
2005-03-01
2019-11-15
Loading full text...

Full text loading...

/deliver/fulltext/jmm/54/3/JM540314.html?itemId=/content/journal/jmm/10.1099/jmm.0.45555-0&mimeType=html&fmt=ahah

References

  1. Babu, G. P., Saraswathi, N. P. & John, T. J. ( 1992;). T-lymphocyte mediated injury of B cells in dual aetiology of diabetes mellitus in Swiss albino mouse. Indian J Exp Biol 30, 769–774.
    [Google Scholar]
  2. Bessen, D. & Fischetti, V. A. ( 1990;). Synthetic peptide vaccine against mucosal colonization by group A streptococci.1. Protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol 145, 1251–1256.
    [Google Scholar]
  3. Bradley, A. ( 2002;). Mining the mouse genome. Nature 420, 512–514.[CrossRef]
    [Google Scholar]
  4. Cunningham, M. ( 2000;). Pathogenesis of group A streptococcal infections. Clin Microbiol Rev 13, 470–511.[CrossRef]
    [Google Scholar]
  5. Dale, J. B., Simmons, M., Chiang, E. C. & Chiang, E. Y. ( 1996;). Recombinant octavalent group A streptococcal M protein vaccine. Vaccine 14, 944–948.[CrossRef]
    [Google Scholar]
  6. Dale, J. B., Chiang, E. Y., Liu, S., Courtney, H. S. & Hasty, D. L. ( 1999;). New protective antigen of group A streptococci. J Clin Invest 103, 1261–1268.[CrossRef]
    [Google Scholar]
  7. Fischetti, V. A. & Bessen, D. ( 1998;). Effect of mucosal antibodies to M protein on colonization by group A streptococci. In Molecular Mechanisms of Microbial Adhesion, pp. 128–142. New York, NY: Springer.
  8. Hall, M. A., Stroop, S. D., Hu, M. C., Walls, M. A., Reddish, M. A., Burt, D. S., Lowell, G. H. & Dale, J. B. ( 2004;). Intranasal immunization with multivalent group A streptococcal vaccine protects mice against intranasal challenge infections. Infect Immun 72, 2507–2512.[CrossRef]
    [Google Scholar]
  9. Harrell, W. K., Ashworth, K., Britt, L. E., Gorge, J. R., Gray, S. B., Green, J. H., Gross, H. & Johnson, J. E. ( 1982;). Preparation of antisera for M types of groups A streptococci. In Procedure Manual for Production of Bacterial, Fungal and Parasitic Reagent, pp. 63–64. Atlanta, GA: Microbiological Reagents Unit, Centers for Disease Control & Prevention.
  10. Holm, S. E. ( 1996;). Invasive group A streptococcal infections. N Engl J Med 335, 590–591.[CrossRef]
    [Google Scholar]
  11. Huber, S. A. & Cunningham, M. W. ( 1996;). Streptococcal M protein peptide with similarity to myosin induces CD4+ T cell-dependent myocarditis in MRL/++ mice and induces partial tolerance against coxsackie viral myocarditis. J Immunol 156, 3528–3534.
    [Google Scholar]
  12. Jebamani, S., Alice, K., Jeyachand, J., Chandi, S. M., Krishnaswami, S. & Brahmadathan, K. N. ( 1998;). Pharyngeal colonization, ADNB response and development of cardiac lesions following intranasal inoculation with group A beta haemolytic streptococcus M type 18. Indian J Exp Biol 36, 292–297.
    [Google Scholar]
  13. Jebamani, S., Kuruvilla, A., Chandi, S., Krishnaswami, S. & Brahmadathan, K. N. ( 1999;). Effects of intranasal challenge with group A beta haemolytic streptococcus M type 49 in Swiss albino mice. Indian J Exp Biol 37, 971–975.
    [Google Scholar]
  14. Ji, Y., Carlson, B., Kondagunta, A. & Cleary, P. ( 1997;). Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococci. Infect Immun 65, 2080–2087.
    [Google Scholar]
  15. Jones, K. F. & Fischetti, V. A. ( 1988;). The importance of the location of antibody binding on the M6 protein for opsonization and phagocytosis of group A M6 streptococcus. J Exp Med 167, 1114–1123.[CrossRef]
    [Google Scholar]
  16. Kaplan, E. L. ( 1991;). The resurgence of group A streptococcal infections and their sequelae. Eur J Clin Microbiol Infect Dis 10, 55–57.[CrossRef]
    [Google Scholar]
  17. Koshi, G., Benjamin, V. & Cherian, G. ( 1981;). Rheumatic fever and rheumatic heart disease in rural South Indian children. Bull World Health Organ 59, 599–603.
    [Google Scholar]
  18. Kotloff, K. L., Corretti, M., Palmer, K., Campbell, J. D., Reddish, M. A., Hu, M. C., Wasserman, S. S. & Dale, J. B. ( 2004;). Safety and immunogenicity of a recombinant multivalent group A streptococcal vaccine in healthy adults: phase 1 trial. JAMA 292, 709–715.[CrossRef]
    [Google Scholar]
  19. Medaglini, D., Pozzi, G., King, T. P. & Fischetti, V. A. ( 1995;). Mucosal and systemic immune responses to a recombinant protein expressed on the surface of the oral commensal bacterium Streptococcus gordonii after oral colonization. Proc Natl Acad Sci 92, 6868–6872.[CrossRef]
    [Google Scholar]
  20. Padmavathi, S. ( 1995;). Present status of rheumatic fever and rheumatic heart disease in India. Indian Heart J 47, 395–398.
    [Google Scholar]
  21. Padmavathi, S. ( 2001;). Rheumatic fever and rheumatic heart disease in India at the turn of the century. Indian Heart J 53, 35–37.
    [Google Scholar]
  22. Pozzi, G., Oggioni, M. R., Manganelli, R. & Fischetti, V. A. ( 1992;). Expression of M6 protein gene of Streptococcus pyogenes in Streptococcus gordonii after chromosomal integration and transcriptional fusion. Res Microbiol 143, 449–457.[CrossRef]
    [Google Scholar]
  23. Smoot, J. C., Barbian, K. D., Van Gompel, J. J. & 15 other authors ( 2002;). Genome sequence and comparative microarray analysis of serotype M 18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc Natl Acad Sci U S A 99, 4668–4673.[CrossRef]
    [Google Scholar]
  24. Veasy, L. G., Tani, L. Y., Daly, J. A., Korgenski, K., Miner, L., Bale, J., Kaplan, E. L., Musser, J. M. & Hill, H. R. ( 2004;). Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics 113, e168–e172.[CrossRef]
    [Google Scholar]
  25. Wannamaker, L. W. ( 1970;). Differences between streptococcal infections of the throat and of the skin. N Engl J Med 282, 23–31.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.45555-0
Loading
/content/journal/jmm/10.1099/jmm.0.45555-0
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error